CA2369183A1 - Moyens et methodes pour evaluer un traitement - Google Patents

Moyens et methodes pour evaluer un traitement Download PDF

Info

Publication number
CA2369183A1
CA2369183A1 CA002369183A CA2369183A CA2369183A1 CA 2369183 A1 CA2369183 A1 CA 2369183A1 CA 002369183 A CA002369183 A CA 002369183A CA 2369183 A CA2369183 A CA 2369183A CA 2369183 A1 CA2369183 A1 CA 2369183A1
Authority
CA
Canada
Prior art keywords
sequence
seq
nucleic acid
type
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002369183A
Other languages
English (en)
Inventor
Antoinette Cornelia Van Der Kuyl
Marion Cornelissen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Primagen Holding BV
Original Assignee
AMSTERDAM SUPPORT DIAGNOSTICS BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP01203703A external-priority patent/EP1298221A1/fr
Application filed by AMSTERDAM SUPPORT DIAGNOSTICS BV filed Critical AMSTERDAM SUPPORT DIAGNOSTICS BV
Publication of CA2369183A1 publication Critical patent/CA2369183A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002369183A 2001-01-23 2002-01-23 Moyens et methodes pour evaluer un traitement Abandoned CA2369183A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP01200228.3 2001-01-23
EP01200228 2001-01-23
US32572201P 2001-09-28 2001-09-28
EP01203703A EP1298221A1 (fr) 2001-09-28 2001-09-28 Moyens et méthodes pour l'évaluation d'un traitement
EP01203703.2 2001-09-28
US60/325,722 2001-09-28

Publications (1)

Publication Number Publication Date
CA2369183A1 true CA2369183A1 (fr) 2002-07-23

Family

ID=27224257

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002369183A Abandoned CA2369183A1 (fr) 2001-01-23 2002-01-23 Moyens et methodes pour evaluer un traitement

Country Status (4)

Country Link
JP (1) JP2004523232A (fr)
CA (1) CA2369183A1 (fr)
NZ (2) NZ537458A (fr)
WO (1) WO2002059558A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2008015425A (es) * 2006-06-02 2008-12-12 Pfizer Prod Inc Ensayo de celulas tumorales circulantes.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470824A (en) * 1991-05-31 1995-11-28 The Regents Of The University Of California Method to treat Kaposi's sarcoma
US5827658A (en) * 1996-08-09 1998-10-27 The United States Of America As Reprsented By The Department Of Health And Human Services Isolation of amplified genes via cDNA subtractive hybridization
US5858715A (en) * 1997-01-29 1999-01-12 Incyte Pharmaceuticals, Inc. Human apoptosis-associated protein
US6333152B1 (en) * 1997-05-21 2001-12-25 The Johnshopkins University Gene expression profiles in normal and cancer cells
AU1853600A (en) * 1999-01-06 2000-07-24 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US6436642B1 (en) * 1999-04-20 2002-08-20 Curagen Corporation Method of classifying a thyroid carcinoma using differential gene expression
DE60027768T2 (de) * 1999-08-17 2007-04-05 Purdue Research Foundation, West Lafayette Behandlung von metastatischer krankheit

Also Published As

Publication number Publication date
WO2002059558A3 (fr) 2003-01-09
NZ537458A (en) 2007-02-23
NZ526924A (en) 2005-09-30
JP2004523232A (ja) 2004-08-05
WO2002059558A2 (fr) 2002-08-01
WO2002059558A8 (fr) 2003-11-06

Similar Documents

Publication Publication Date Title
Reines et al. The RNA polymerase II general elongation factors
de Waard et al. Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus
US20050208486A1 (en) Brca-1 regulators and methods of use
Hutchinson et al. Modulation of vascular development and injury by angiotensin II
van der Reijden et al. RT-PCR diagnosis of patients with acute nonlymphocytic leukemia and inv (16)(p13q22) and identification of new alternative splicing in CBFB-MYH11 transcripts
EP1400596A1 (fr) Protéine associée au complexe de récepteur d'androgène A
Scurto et al. A multiplex RT-PCR assay for the detection of chimeric transcripts encoded by the risk-stratifying translocations of pediatric acute lymphoblastic leukemia
JP2003102485A (ja) 創傷治癒バイオマーカー
Shilatifard The RNA polymerase II general elongation complex
Cong et al. Hhex is a direct repressor of endothelial cell-specific molecule 1 (ESM-1)
US6043340A (en) Association of kinesin with sensitivity to chemotherapeutic drugs
CA2369183A1 (fr) Moyens et methodes pour evaluer un traitement
JP2003510028A (ja) ２５個のヒト分泌タンパク質
US20030219772A1 (en) Means and methods for treatment evaluation
US20030170720A1 (en) Means and methods for treatment evaluation
AU689840B2 (en) Association of kinesin with sensitivity to chemotherapeutic drugs
EP1225233A2 (fr) Moyens et méthodes pour l'évaluation d'un traitement
CN108841958A (zh) 一种检测EGFR基因外显子21L858突变的crRNA及其检测方法
Harada et al. ETS‐dependent enhancers for endothelial‐specific expression of serum/glucocorticoid‐regulated kinase 1 during mouse embryo development
Arkenbout et al. Focusing on transcription factor families in atherogenesis: the function of LKLF and TR3
EP1298221A1 (fr) Moyens et méthodes pour l'évaluation d'un traitement
AU2002228477A1 (en) Means and methods for treatment evaluation
EP1424391A1 (fr) Ensemble de genes participant a l'activation des astrocytes du foie
US20060281083A1 (en) Identification of genes involved in angiogenesis, and development of an angiogenesis diagnostic chip to identify patients with impaired angiogenesis
JP2003527860A (ja) Ｂｒｃａ−１制御因子およびその使用方法

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead